The present invention relates to new cyclopropyl modulators of P2Y12 receptor activity, pharmaceutical compositions thereof, and methods of use thereof
本发明涉及P2Y12受体活性的新环丙基调节剂,其制药组合物以及使用方法。
Controlled generation hypochlorite compositions and method
申请人:The Clorox Company
公开号:EP0168253A2
公开(公告)日:1986-01-15
A dry bleaching composition, particularly useful for low temperature applications, is provided in which generation of hypochlorite by reaction between a peroxygen bleaching agent and a chloride salt is promoted by an aromatic diol or oxidized aromatic diol activator. Preferred activators are in ester form and provide hypochlorite generation at levels of less than about 20 ppm for at least about the first two minutes following dissolution of the compositions in aqueous solution, but rising to effective bleaching levels within a reasonable time thereafter. The initially low hypochlorite level assists in the functioning of laundry additives, such as fabric brighteners.
2,5-dihydroxybenzene compounds for the treatment of of cancer of an organ
申请人:Action Medicines, S.L.
公开号:EP2620145A2
公开(公告)日:2013-07-31
The present invention refers to the use of a compound of Formula (I") or pharmaceutically acceptable salt or solvate, isomer or prodrug thereof in the manufacturing of a medicament for the treatment and/or prophylaxis of cancer of an organ.
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of glioma
申请人:AmDerma Pharmaceuticals, LLC
公开号:US10278941B2
公开(公告)日:2019-05-07
The present invention relates to the use of a 2,5-dihydroxybenzene derivative of formula (I) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of, inter alia, rosacea.
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
申请人:AmDerma Pharmaceuticals, LLC
公开号:US10278940B2
公开(公告)日:2019-05-07
The present invention relates to the use of a 2,5-dihydroxybenzene derivative of formula (I) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of, inter alia, skin cancer.